文献速递妇产科病理细胞病理与分子病理

细胞病理学评估可准确识别腹水中高级别浆液性癌的免疫表型特征及BRCA1/2突变

Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high-grade serous carcinoma from ascites.
PubMed 文献 · Cancer Cytopathol · 2022-11-18

本研究纳入45例组织学确诊的原发性高级别浆液性癌(HGSC)伴恶性腹水患者,评估细胞病理学识别HGSC免疫表型及BRCA1/2突变的准确性。结果显示,PAX8、WT1、P53和P16的免疫细胞化学与组织免疫组化结果可靠性良好(α>0.75),胚系BRCA1/2突变一致率达100%,但Ki-67可靠性差(α<0.26;p<.001)且体细胞BRCA1/2突变一致率仅14%。

要点

  • 腹水细胞学可准确评估HGSC的PAX8、WT1、P53、P16免疫表型。
  • 腹水细胞学检测胚系BRCA1/2突变与组织一致率达100%。
  • Ki-67增殖活性及体细胞BRCA1/2突变检测可靠性不足。

核心结论

  • 细胞病理学是识别腹水中HGSC免疫表型特征和检测胚系BRCA1/2突变的准确方法。
  • 腹水中HGSC的增殖活性评估及体细胞BRCA1/2突变检测仍需进一步研究。

研究设计与样本

  • 纳入45例组织学确诊的原发性HGSC伴恶性腹水患者。
  • 对腹水细胞离心涂片和细胞块进行PAX8、WT1、P53、P16和Ki-67免疫细胞化学染色。
  • 采用二代测序(NGS)检测腹水中胚系/体细胞BRCA1/2突变。
  • 将免疫细胞化学和NGS结果与原发性肿瘤组织块的免疫组化和NGS结果进行比较。
  • 使用Cronbach α和χ2统计量进行分析。

主要发现

  • PAX8、WT1、P53和P16的免疫细胞化学/免疫组化结果在细胞离心涂片、细胞块和组织块之间显示良好可靠性(α>0.75)。
  • Ki-67在腹水与组织块之间可靠性差且差异显著(α<0.26;p<.001 [Kruskal-Wallis])。
  • 胚系BRCA1/2突变一致率为100%。
  • 体细胞BRCA1/2突变一致率仅为14%。

关键数值与推荐

  • PAX8、WT1、P53和P16的免疫细胞化学/免疫组化可靠性良好:α>0.75。
  • Ki-67可靠性差:α<0.26;p<.001(Kruskal-Wallis检验)。
  • 胚系BRCA1/2突变一致率:100%。
  • 体细胞BRCA1/2突变一致率:14%。

临床怎么用

  • 腹水细胞学标本可用于HGSC的PAX8、WT1、P53和P16免疫表型评估。
  • 腹水细胞学标本可用于检测胚系BRCA1/2突变。
  • 不建议依据腹水细胞学Ki-67评估HGSC增殖活性。
  • 体细胞BRCA1/2突变检测需谨慎解释腹水细胞学结果。

局限性

  • 体细胞BRCA1/2突变检测一致率低(14%),需进一步研究。
  • Ki-67在腹水与组织间可靠性差,增殖活性评估受限。
  • 样本量有限(45例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: High-grade serous carcinoma (HGSC) is the most common and aggressive type of ovarian cancer, and it is often associated with ascites at presentation. The objective of this study was to evaluate the accuracy of cytopathology to identify immunophenotypic features of HGSC and BRCA1/2 mutations from ascites. METHODS: The study included 45 patients with histologically confirmed primary HGSC and malignant ascites. Immunocytochemistry (ICC) staining for PAX8, WT1, P53, P16, and Ki-67 was performed on cytospins and cytoblocks prepared from ascites. Next-generation sequencing (NGS) was used to detect germline/somatic BRCA1/2 mutations in the ascites. Both ICC and NGS results were compared with immunohistochemistry (IHC) and NGS results from tissue blocks of primary tumor. Cronbach α and χ2 statistics, respectively, were used. RESULTS: ICC/IHC results for PAX8, WT1, P53, and P16 showed good reliability between cytospins, cytoblocks, and tissue blocks (α > 0.75), whereas poor reliability and significant differences were observed for Ki-67 between ascites and tissue blocks (α < 0.26; p < .001 [Kruskal-Wallis]). For germline BRCA1/2 mutations, 100% concordance was confirmed, but only 14% concordance was confirmed for somatic mutations. CONCLUSIONS: These results demonstrate that cytopathology is an accurate method for identifying immunophenotypic features of HGSC and detecting germline BRCA1/2 mutations from ascites. However, further investigation is required for assessing the proliferation activity of HGSC in ascites and for detecting somatic BRCA1/2 mutations.

来源:Cancer Cytopathol,查看原文。版权归原作者所有。

引用

  1. Miceska S, Škof E, Novaković S, et al. Cytopathological assessment is an accurate method for identifying immunophenotypic features and BRCA1/2 mutations of high-grade serous carcinoma from ascites. Cancer Cytopathol. 2022. PMID: 36399410. doi:10.1002/cncy.22664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。